Intrinsic Value

The intrinsic value of Schrodinger Inc (SDGR) under the Base Case is 17.08 USD per share. Compared with the current market price of 23.86 USD, the stock appears Overvalued by 28% .

The intrinsic value is calculated using the DCF method.

Do our valuations actually work? See backtest results .

SDGR Intrinsic Value
$17.08
Overvaluation 28%
Intrinsic Value
Price $23.86

SDGR is cheaper than usual. Still overvalued, but less so than on 82% of days in the past 5 years.

Monitor SDGR
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value $13.67
Get notified when the price drops into your buy zone
Current Price $23.86
Intrinsic Value $17.08
Margin of Safety 20% $13.67
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to SDGR

Fundamental Analysis

What Schrodinger Does

Health Care

Schrödinger makes software that helps scientists predict how molecules will behave before they run expensive lab experiments. Its main products are computational chemistry tools used for drug discovery and for designing materials. The company sells these tools to pharmaceutical and biotech companies, researchers, and some industrial customers that need to model chemistry at the atomic level.

Headquarters
United States of America US
Employees
850
IPO date
Feb 6, 2020
Read the full company overview
View Company Overview

Schrodinger has no economic moat

No Moat Narrow Wide

Schrodinger Inc lacks an economic moat, leaving it vulnerable to competitive pressures and market challenges.

Read the full moat analysis
Financials
Efficiency

Earnings Waterfall
Schrodinger Inc

Wall St Price Targets

Capital Returns

Competitive Landscape

Ownership

SDGR Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one SDGR stock?

The intrinsic value for Schrodinger Inc (SDGR) under the Base Case is 17.08 USD.

Is SDGR stock undervalued or overvalued?

Compared with the current market price of 23.86 USD, the stock appears Overvalued by 28% .

Back to Top